Background Since the publication of the British Thoracic Society (BTS) Guideline on the
'Management of opportunistic mycobacterial infections' in 2000, our understanding of the …

Non-tuberculous mycobacteria (NTM) are emerging worldwide as significant causes of
chronic pulmonary infection, posing a number of challenges for both clinicians and …

There are over 170 known species and subspecies of mycobacteria that have been
identified, and new species continue to be discovered (http://www. bacterio …

Microbiological Diagnosis of Nontuberculous Mycobacterial Pulmonary Disease - Clinics in Chest
Medicine Skip to Main Content Clinics in Chest Medicine Log in Register Log in Subscribe Claim …

Immunological mechanisms of susceptibility to nontuberculous mycobacterial (NTM)
disease are poorly understood. To understand NTM pathogenesis, we evaluated innate and …

Introduction Nontuberculous mycobacteria (NTM) are a diverse group of mycobacterial
species that are ubiquitous in the environment. They are opportunistic pathogens that can …

Currently, an anti-glycopeptidolipid (GPL)-core IgA antibody assay kit for diagnosing
Mycobacterium avium complex (MAC) is commercially available. We conducted this …

Background The risk factors for Mycobacterium avium complex lung disease (MAC-LD) are
not well known. We hypothesized that low serum estradiol (E2) levels are related to MAC-LD …

Although serum anti-glycopeptidolipid (GPL)-core IgA antibody is a highly specific test for
infection with Mycobacterium avium complex (MAC), Mycobacterium abscessus, and its …

Nontuberculous mycobacteria (NTM) infections are increasingly prevalent in chronic lung
diseases, including cystic fibrosis (CF). Mycobacterium abscessus is of particular concern …